Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria

International Journal of STD and AIDS

Volumn 25, Issue 5, 2014, Pages 355-359

  Parrish, Deidra D ^a   Blevins, Meridith ^a   Megazzini, Karen M ^b   Shepherd, Bryan E ^a   Mohammed, Mukhtar Y ^c   Wester, C William ^a   Vermund, Sten H ^a   Aliyu, Muktar H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b WESTAT   (United States)

^c Friends in Global Health   (Nigeria)

Author keywords

Africa; AIDS; anaemia; antiretroviral therapy; AZT; haemoglobin; HIV; zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; COMBINATION ANTIRETROVIRAL THERAPY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FUNCTIONAL STATUS; HEMOGLOBIN DETERMINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

AFRICA; AIDS; ANAEMIA; ANTIRETROVIRAL THERAPY; AZT; HAEMOGLOBIN; HIV; ZIDOVUDINE;

ADULT; ANEMIA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NIGERIA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RURAL POPULATION; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 84898684369     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413506887     Document Type: Article

References (17)

1. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: WHO Press; 2010:.
2. Richman D,Fischl M,Grieco M, et alThe toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.N Engl J Med. 1987;317:192-197.
3. Matsushita S,Yoshimura K,Kimura T, et alSpontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on long-term Combivir containing regimen.J Clin Virol. 2005;33:188-193.
4. Sullivan P,Hanson D,Brooks J.Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients.J Acquir Immune Defic Syndr. 2008;48:163-168.
5. Kiragga A,Castelnuovo B,Nakanjako D, et alBaseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.J Int AIDS Soc. 2010;13:42 doi:10.1186/1758-2652-13-42-42 doi:10.1186/1758-2652-13-42.
6. Ssali F,Stohr W,Munderi P, et alPrevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.Antivir Ther. 2006;11:741-749.
7. Zhou J,Jaquet A,Bissagnene E, et alShort-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific and central and South America.J Int AIDS Soc. 2012;15:5 doi:10.1186/1758-2652-15-5-5 doi:10.1186/1758-2652-15-5.
8. Saracino A,Nacarapa EA,da Costa Massinga EA, et alPrevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique.Malar J. 2012;11:241-241.
9. Modjarrad K,Zulu I,Redden DT, et alPrevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting.Am J Trop Med Hyg. 2005;73:777-782.
10. Walson JL,Stewart BT,Sangare L, et alPrevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.PLoS Negl Trop Dis. 2010;4:e644-e644.
11. Onyenekwe C,Ele P,Ukibe N, et alAssessment of white blood cell count, packed cell volume, phagocytic functions, serum albumin and plasma iron in HIV infected patients.Clin Immunol. 2010;135:S110-S110.
12. Akinbo FO,Okaka CE,Omoregie R.Plasmodium falciparum and intestinal parasitic co-infections in HIV-infected patients in Benin City, Edo State, Nigeria.J Infect Dev Ctries. 2012;6:430-435.
13. Igbedioh SO.Undernutrition in Nigeria: dimension, causes and remedies for alleviation in a changing socio-economic environment.Nutr Health. 1993;9:1-14.
14. Federal Ministry of Health. National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja, Nigeria: Ministry of Health - Nigeria, 2010.
15. Laird NM,Ware JH.Random-effects models for longitudinal data.Biometrics. 1982;38:963-974.
16. Hastie TJStatistical models in S. Chambers JMHastie TJ, ed. Danvers, MA: Chapman and Hall/CRC; 1992:.
17. Moh R,Danel C,Sorho S, et alHaematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire.Antivir Ther. 2005;10:615-624.